| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,237 |
10,745 |
$674K |
| 99199 |
Unlisted special service, procedure or report |
44,322 |
27,313 |
$255K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,582 |
3,604 |
$160K |
| 20610 |
|
4,006 |
1,129 |
$45K |
| 99401 |
|
2,397 |
1,370 |
$28K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
415 |
239 |
$27K |
| 99406 |
|
2,044 |
1,340 |
$12K |
| 80305 |
|
2,762 |
1,937 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,902 |
1,890 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,062 |
461 |
$7K |
| 82962 |
|
5,716 |
3,624 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,951 |
1,072 |
$3K |
| 99407 |
|
296 |
186 |
$3K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
27 |
12 |
$3K |
| 81002 |
|
2,782 |
1,802 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
481 |
313 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
298 |
168 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
259 |
160 |
$2K |
| 90686 |
|
269 |
163 |
$1K |
| 94060 |
|
60 |
29 |
$1K |
| 90756 |
|
405 |
160 |
$1K |
| 97760 |
|
173 |
93 |
$1K |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
791 |
446 |
$996.00 |
| 90656 |
|
85 |
78 |
$597.32 |
| G9919 |
Screening performed and positive and provision of recommendations |
37 |
31 |
$500.80 |
| 90688 |
|
98 |
80 |
$406.71 |
| 72100 |
|
41 |
25 |
$406.32 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
230 |
115 |
$272.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,744 |
1,559 |
$248.54 |
| 3044F |
|
504 |
372 |
$200.20 |
| G0008 |
Administration of influenza virus vaccine |
467 |
272 |
$137.46 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,700 |
1,714 |
$132.39 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
29 |
13 |
$64.76 |
| G0246 |
Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education |
15 |
14 |
$29.98 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
11,664 |
7,205 |
$6.77 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
948 |
597 |
$3.65 |
| 3074F |
|
4,235 |
2,865 |
$0.31 |
| 3078F |
|
4,262 |
2,961 |
$0.28 |
| 3080F |
|
1,858 |
1,335 |
$0.24 |
| 3077F |
|
3,067 |
2,289 |
$0.24 |
| 3079F |
|
3,218 |
2,294 |
$0.21 |
| 3075F |
|
2,040 |
1,457 |
$0.18 |
| 1036F |
|
6,660 |
4,273 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
4,311 |
2,672 |
$0.00 |
| 1034F |
|
59 |
40 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
369 |
168 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,862 |
1,172 |
$0.00 |
| 3008F |
|
863 |
591 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
283 |
197 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
13 |
12 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
19 |
15 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,450 |
923 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
7,066 |
4,406 |
$0.00 |
| 4004F |
|
1,646 |
1,117 |
$0.00 |
| 1159F |
|
334 |
218 |
$0.00 |
| 4274F |
|
171 |
154 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
724 |
469 |
$0.00 |
| 1160F |
|
902 |
618 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
42 |
39 |
$0.00 |